Company Filing History:
Years Active: 2020
Title: Bartosz Gryzbowski: Innovator in Nanotechnology for Cancer Treatment
Introduction
Bartosz Gryzbowski is a prominent inventor based in Evanston, IL (US). He has made significant contributions to the field of nanotechnology, particularly in the development of innovative solutions for cancer treatment. His work focuses on the application of metal oxide nanoparticles in medical science.
Latest Patents
Gryzbowski holds a patent for a groundbreaking invention titled "Metal oxide nanoparticle for cell lysis." This patent describes a nanostructure that comprises a metal oxide nanoparticle (MOX NP) and a bidentate ligand on its surface. A cancer recognition molecule is covalently coupled to the surface of the MOX NP via the bidentate ligand. Additionally, a biocatalyst is also attached to the surface of the MOX nanoparticle through the same ligand. The cancer recognition molecule is designed to selectively identify and bind to antigens present on cancer cells. The biocatalyst is engineered to catalyze the oxidation of a light-emitting compound, producing photons that excite the MOX NPs. This excitation leads to the generation of reactive oxygen species (ROS) that can lyse or induce apoptosis in cancer cells in situ.
Career Highlights
Gryzbowski is affiliated with UChicago Argonne, LLC, where he continues to advance his research in nanotechnology and its applications in medicine. His innovative approach to cancer treatment through nanostructures has garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include Tijana Rajh and Elena A Rozhkova, who contribute to the collaborative efforts in research and development within the field.
Conclusion
Bartosz Gryzbowski's work exemplifies the intersection of nanotechnology and cancer treatment, showcasing the potential of innovative solutions in addressing complex medical challenges. His contributions are paving the way for future advancements in the field.